Intelligent Bio Solutions... (INBS)
NASDAQ: INBS
· Real-Time Price · USD
1.20
-0.08 (-6.25%)
At close: May 06, 2025, 3:59 PM
1.21
0.83%
After-hours: May 06, 2025, 06:39 PM EDT
-6.25% (1D)
| Bid | 1.2 |
| Market Cap | 8.17M |
| Revenue (ttm) | 3.03M |
| Net Income (ttm) | -10.69M |
| EPS (ttm) | 0.12 |
| PE Ratio (ttm) | 10 |
| Forward PE | 3.6 |
| Analyst | n/a |
| Ask | 1.41 |
| Volume | 40,542 |
| Avg. Volume (20D) | 180,528 |
| Open | 1.24 |
| Previous Close | 1.28 |
| Day's Range | 1.20 - 1.27 |
| 52-Week Range | 1.00 - 3.04 |
| Beta | 4.63 |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
1 month ago
-16.59%
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
2 months ago
-20.45%
Intelligent Bio Solutions shares are trading lower after the company announced a $2.6 million proposed public offering of common stock.
